Streetbeat News

ELV

Elevance Health Inc.

https://www.elevancehealth.com

Industry

Medical - Healthcare Plans

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Open

405.00

Mkt cap

93B

Volume

2.6M

High

408.58

P/E Ratio

14.58

52-wk high

567.26

Low

398.69

Div yield

0.02

52-wk low

397.98

Elevance Health (NYSE:ELV) received 6 somewhat bullish ratings from analysts over the last three months, with an updated average 12-month price target of $563.17, marking a 0.66% increase from the previous target. The company, a leading U.S. health insurer and the largest provider of Blue Cross Blue Shield branded coverage, reported a revenue growth of 6.81% as of December 31, 2023, and outperformed industry averages in net margin, ROE, and ROA, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 2:00 pm

Barclays analyst Andrew Mok initiates coverage on Elevance Health (ELV) with an Overweight rating and a price target of $584.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:30 am

Elevance Health's four Medicare Advantage contracts will receive higher 2024 Star Ratings, positively impacting its 2025 revenue by an estimated $190M. This adjustment follows a reconsideration of the initial ratings announced in October 2023.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 11:18 am

Elevance Health has reaffirmed its 2024 net income guidance, projecting over $34.29 per diluted share and over $37.10 on an adjusted basis, surpassing the consensus estimate of $37.05, as reported in an 8K filing.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 11:16 am

Elevance Health (NYSE:ELV) has delivered an impressive average annual return of 18.49% over the past 10 years, outperforming the market by 8.05% on an annualized basis. An initial investment of $1000 in ELV stock a decade ago would be worth $5,501.60 today, showcasing the significant impact of compounded returns on investment growth. Elevance Health currently boasts a market capitalization of $116.24 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 6:00 pm

Elevance Health (NYSE:ELV) has received 7 analyst ratings in the last three months, all somewhat bullish, with a recent shift in sentiment and price targets. The average 12-month price target is now $556.29, down from $562.67. Elevance Health, a leading U.S. health insurer and the largest provider of Blue Cross Blue Shield branded coverage, faces revenue challenges with a -0.47% decline but shows strong profitability and financial health indicators.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 2:00 pm

Cantor Fitzgerald analyst Sarah James has maintained an Overweight rating on Elevance Health (NYSE:ELV) and increased the price target from $547 to $580.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:45 pm

Elevance Health (NYSE:ELV) has delivered an average annual return of 13.35% over the past 20 years, outperforming the market by 5.81%. A $100 investment in ELV 20 years ago would be worth $1,219.54 today. Elevance Health currently has a market capitalization of $118.23 billion.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 8:30 pm

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $547.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:09 pm

Elevance Health (NYSE:ELV) has delivered an average annual return of 13.11% over the past 20 years, outperforming the market by 5.64% annually. A $1000 investment in ELV 20 years ago would be worth $11,921.72 today. The company currently has a market capitalization of $115.94 billion.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 2:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.